Clinical Drug Experience Knowledgebase

Alzheimer Disease (Phase 1)

Amyotrophic Lateral Sclerosis (Phase 1)

Arthritis (Phase 4)

Arthritis, Rheumatoid (Phase 4)

Brain Injuries (Phase 3)

Brain Injuries, Traumatic (Phase 3)

Brugada Syndrome (Phase 3)

Cognitive Dysfunction (Phase 1)

Colorectal Neoplasms (Phase 2)

Congenital Abnormalities (Phase 2)

Endocarditis (Phase 3)

Endocarditis, Bacterial (Phase 3)

Eye Diseases (Phase 4)

Fibrosis (Phase 4)

Hypoxia-Ischemia, Brain (Phase 2)

Infections (Phase 2)

Keratitis (Phase 4)

Laryngeal Diseases (Phase 3)

Laryngeal Neoplasms (Phase 3)

Leukemia (Phase 3)

Leukemia, Lymphocytic, Chronic, B-Cell (Phase 3)

Leukemia, Lymphoid (Phase 3)

Lichen Planus (Phase 3)

Lichen Planus, Oral (Phase 3)

Lung Diseases (Phase 3)

Lung Diseases, Interstitial (Phase 3)

Motor Neuron Disease (Phase 1)

Mouth Neoplasms (Phase 3)

Multiple Myeloma (Phase 3)

Neoplasms, Plasma Cell (Phase 3)

Neutropenia (Phase 2)

Oropharyngeal Neoplasms (Phase 3)

Pneumonia (Phase 3)

Respiratory Insufficiency (Phase 2)

Retinal Neoplasms (Phase 2)

Retinoblastoma (Phase 2)

Scabies (Phase 3)

Sclerosis (Phase 1)

Seizures (Phase 2)

Spinal Diseases (Phase 1)

Spondylitis (Phase 4)

Spondylitis, Ankylosing (Phase 4)

Squamous Cell Carcinoma of Head and Neck (Phase 3)

Syndrome (Phase 3)

Urticaria (Phase 3)

Vascular Malformations (Phase 2)